Diabetes REarCh on patient sTratification (DIRECT) work package 3.2: metformin intolerance

Diabetes REarCh on patient sTratification (DIRECT) work package 3.2: metformin intolerance - DIRECT metformin intolerance

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38746

Enrollment

150

Registered

2013-06-07

Start date

2013-06-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Written informed consent Patients with Type 2 diabetes White European Potential metformin intolerance

Exclusion criteria

Exclusion criteria: - Type 1 diabetes - Age at study start 90 - Inability to consent

Design outcomes

Primary

Measure	Time frame
First a biorepository containing genetic profiles, biochemical and clinical characteristics of the patients will be constructed. This biorepository will be used to identify predictive biomarkers (clinical, genetic and genomic) of metformin intolerance.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results